T1	Participants 355 385	subjects diagnosed with an ASD
T2	Participants 144 174	autism spectrum disorder (ASD)
T3	Participants 545 686	trial using oral lipoceutical glutathione (n=13) or transdermal glutathione (n=13) in children, 3-13 years of age, with a diagnosis of an ASD
#1	AnnotatorNotes T3	Total of 26 participants.
T4	Participants 1371 1401	subjects diagnosed with an ASD
